Immunocytokines: a review of molecules in clinical development for cancer therapy

Immunocytokines: a review of molecules in clinical development for cancer therapy

Thomas List, Dario NeriDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, SwitzerlandAbstract: The concept of therapeutically enhancing the immune system’s responsiveness to tumors is long standing. Several cytokines have b...

Full description

Bibliographic Details
Main Authors:	List T, Neri D
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-08-01
Series:	Clinical Pharmacology: Advances and Applications
Online Access:	http://www.dovepress.com/immunocytokines-a-review-of-molecules-in-clinical-development-for-canc-a14092

Similar Items

Immunocytokines
by: Katrin L. Gutbrodt, et al.
Published: (2012-05-01)

Utilizing Immunocytokines for Cancer Therapy
by: Erin Runbeck, et al.
Published: (2021-03-01)

Immunocytokines with activity-on-demand by combination with small molecule inhibitors
by: Dafne Müller
Published: (2024-03-01)

A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors
by: Giulia Rotta, et al.
Published: (2024-03-01)

Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine
by: Christine M. Minnar, et al.
Published: (2024-01-01)

NHS-IL12, a Tumor-Targeting Immunocytokine
by: Greiner JW, et al.
Published: (2021-05-01)

1159 A targeted masked ImmunoCytokine for CD138 expressing cancers
by: Ryan Trinh, et al.
Published: (2023-11-01)

Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
by: Tzeng, Alice, et al.
Published: (2015)

Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy
by: Ana Victoria Casadesús, et al.
Published: (2022-12-01)

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
by: Christian Klein, et al.
Published: (2017-03-01)

Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation
by: Maciej Kujawski, et al.
Published: (2020-01-01)

Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy
by: Keunok Jung, et al.
Published: (2022-10-01)

A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic
by: Arezoo Beig Parikhani, et al.
Published: (2024-02-01)

824 Synergistic effects of a therapeutic cancer vaccine, an immunocytokine, and an HDAC inhibitor in an HPV tumor model
by: Jeffrey Schlom, et al.
Published: (2023-11-01)

Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
by: Inja Waldhauer, et al.
Published: (2021-01-01)

Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines
by: Zulmarie Perez Horta, et al.
Published: (2019-06-01)

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
by: Nicolle H. Rekers, et al.
Published: (2018-04-01)

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
by: Seung E. Cha, et al.
Published: (2021-01-01)

Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.
by: Melissa Paoloni, et al.
Published: (2015-01-01)

Correction: Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model
by: Hannan Gao, et al.
Published: (2020-07-01)

Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12
by: Y. Maurice Morillon, et al.
Published: (2019-06-01)

1063 Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12
by: Renee N Donahue, et al.
Published: (2023-11-01)

1365 An immunocytokine with target cell-restricted IL-15 activity for induction of anti-tumor immunity against acute myeloid leukemia
by: Melanie Märklin, et al.
Published: (2023-11-01)

The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD<sub>2</sub> Antibody Dinutuximab Beta
by: Nikolai Siebert, et al.
Published: (2022-10-01)

Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen
by: Anna Hoefges, et al.
Published: (2023-11-01)

Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma
by: Paul D. Bates, et al.
Published: (2021-08-01)

712 Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties
by: Anika Jaekel, et al.
Published: (2021-11-01)

Effects of Immunocytokine Combined with Cattle Encephalon Glycoside and Ignotin on CTGF, HO-1 and NT-3 in Patients with Type 2 Diabetic Peripheral Neuropathy
by: Jianguo SUN, et al.
Published: (2017-11-01)

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma
by: Gillies Stephen D, et al.
Published: (2009-07-01)

Application of gas molecules in cancer therapy
by: Danna Liang, et al.
Published: (2024-06-01)

Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules
by: Nasrulla Abdullaevich Shanazarov, et al.
Published: (2024-03-01)

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1+tumor infiltrating lymphocytes and potentiate anti-tumor efficacy
by: Ulrich Moebius, et al.
Published: (2023-11-01)

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
by: Paola Orecchia, et al.
Published: (2019-08-01)

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance
by: Xiaoling Song, et al.
Published: (2023-09-01)

Synthetic Routes and Clinical Application of Representative Small-Molecule EGFR Inhibitors for Cancer Therapy
by: Ya-Tao Wang, et al.
Published: (2024-03-01)

Small molecule-based immunomodulators for cancer therapy
by: Yinrong Wu, et al.
Published: (2022-12-01)

Small-molecule bromodomain inhibitors for cancer therapy
by: Qi, J, et al.
Published: (2010)

Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy
by: T. M. Mohiuddin, et al.
Published: (2023-01-01)

1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy
by: Caroline Mary, et al.
Published: (2023-11-01)

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
by: Xiaoli Pan, et al.
Published: (2022-05-01)